Becker's Hospital Review

90 POPULATION HEALTH 90 CEO/STRATEGY Dr. John Noseworthy: All of these unconventional healthcare partnerships will spark innovation By Julie Spitzer A number of new forces are entering the healthcare are- na with the potential for serious disruption, causing some concern for healthcare veterans. However, Pres- ident and CEO of Rochester, Minn.-based Mayo Clinic John Noseworthy, MD, says there's no need to worry: some of the best innovations have sprung up in unlikely places through un- conventional collaborations, he argues in an op-ed for CNBC. It's no secret the healthcare industry is ripe for disruption and innovation. Dr. Noseworthy points out that Mayo sees potential for revolution in spaces like biotherapeutics, mo- lecular imaging, genomics and software development. But, the U.S. healthcare system is unsustainable as it sits, and industry players must put their heads together to come up with better, cheaper and faster ways of delivering care to keep up with the needs of patients and payers. Dr. Noseworthy adds that at the same time, the physical, digi- tal and biological worlds are merging, thereby connecting every aspect of humans' lives. "Amid our excitement about the future of medicine, how- ever, we recognize two things," he writes. "[One,] disrup- tive innovation in healthcare will emerge from our blind spots, and [two,] we must seek partners who can help us see the whole picture." These ideas aren't really anything new to Mayo. For exam- ple, when researchers at Mayo discovered cortisone ben- efits treating arthritis, Mayo couldn't scale the innovation. Instead, Merck did. "It's clear that we need to work with partners to ensure our ideas can be scaled to benefit pa- tients," Dr. Noseworthy writes. Mayo's department of business development serves as a central hub for its startups, license agreements, partnerships, joint ventures, acquisitions and venture investing. Some of its collaborations include GeneSight, a genetic test developed with Myriad, or Cologuard, a noninvasive, colorectal cancer screening test developed with Exact Sciences. "Now more than ever, stakeholders must reach beyond orga- nizational boundaries to create significant medical progress and a sustainable, patient-centered healthcare system," he writes. "With many complex challenges to solve, patients are counting on the combined problem-solving power of sea- soned industry leaders and visionary neophytes. We need both to quickly move from innovation to patient impact." n Scripps promotes 6 physicians to lead system's restructuring By Leo Vartorella S an Diego-based Scripps Health promot- ed one physician leader to the chief op- erations executive/physician job at each of its five campuses and filled a regional phy- sician leadership role for its southern region as part of its organizational restructuring. Scripps CEO Chris Van Gorder announced the restructuring in December 2017, adopt- ing a regional CEO model where each hos- pital is led jointly by a chief operations ex- ecutive/administrator and chief operations executive/physician. e new chief operations executive/physi- cians are Dan Dworsky, MD, Scott Eisman, MD, Jon Worsey, MD, Valerie Norton, MD and Juan Tovar, MD. Davis Cracro, MD, was named vice president of physician network development for the system's south region. Here are Mr. Van Gorder's descriptions of the system's new leaders included in a memo to all Scripps employees. 1. Dr. Worsey: Currently system medical di- rector of value analysis and system medical di- rector of the surgery care line. He has an active surgical practice at Scripps La Jolla (Calif.) and will partner as an operating dyad with Cindy Steckel, PhD, RN, the current chief operating executive/administrator at Scripps La Jolla. 2. Dr. Dworsky: Currently vice president at Scripps Clinic and an internist with an active hospitalist practice. He will partner as an op- erating dyad with Tim Collins, chief operat- ing executive/administrative at La Jolla, Ca- lif.-based Scripps Green Hospital. 3. Dr. Tovar: Currently medical director of quality at San Diego-based Scripps Mercy and an emergency physician at Scripps Chula Vista (Calif.). He will partner as an operat- ing dyad with Deb McQuillen, chief operat- ing executive/administrative-Scripps Mercy Hospital at Scripps Chula Vista. 4. Dr. Eisman: Immediate past chief of staff at Scripps Encinitas (Calif.) and a pulmonary/ critical care physician with an active practice at Encinitas. He will partner as an operating dyad with Jan Zachry, BSN, chief operating executive/administrative at Scripps Encinitas. 5. Dr. Norton:Medical director of the Scripps Mercy emergency department, chair of Scripps System Pharmacy and erapeutics Council, who maintains an active practice in emergency medicine. She will partner as an operating dyad with Deb McQuillen, RN, chief operating executive /administrative at Scripps Mercy Hospital. 6. Dr. Cracro: Currently senior director of medical affairs at Scripps Mercy Hospital and an emergency physician. He will be promot- ed to a regional system role as vice president of physician development in the health sys- tem's south region. In this role, Dr. Cracro will work with senior leadership to develop key strategic partnerships with private phy- sicians, aligned medical groups, community partners like federally qualified health centers and strategic partners like Houston-based MD Anderson. In addition, he will play a significant role in planning the replacement hospital for Scripps' San Diego campus. Dr. Cracro brings a wealth of experience and skills to this work, which makes him uniquely qualified for the role. n

• Cover